Tim S.
- Country
- Germany
- Department
- Universitätsklinikum Heidelberg, Medizinische Klinik und Poliklinik V
Research Overview
- Phase 1 Evaluation of JNJ-88549968, a T-cell Redirecting Antibody, in Patients with CALR-mutated Myeloproliferative Neoplasms
- An open-label, single-arm, pilot study of Venetoclax in combination with 5 days Azacitidine in treatment-naïve subjects with acute myelogenous leukemia who are ≥18 years of age and not eligible for standard induction therapy (VENAZA-5S PILOT TRIAL)
- Efficacy of Venetoclax and Azacitidine Versus Standard Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia with NPM1 Mutations
Data & Insights
Has run more than one trial at 185 of 391 partner sites.
Specializations
Acute Myeloid Leukemia Research
The investigator specializes in developing innovative treatments for acute myeloid leukemia (AML), with particular focus on both newly diagnosed and treatment-resistant cases.
- Novel Therapeutic Combinations
- Targeted Therapies for AML Mutations
- Intensive Chemotherapy Approaches
Their work encompasses treatment strategies for various AML patient populations, including those eligible and ineligible for intensive chemotherapy.
Myeloid Disorders
The investigator conducts research in various myeloid conditions, including myelodysplastic syndromes and chronic myeloid leukemia.
- High-Risk MDS Treatment
- Stem Cell Transplantation Approaches
- CML Management Strategies
Their research extends to developing treatment protocols for patients requiring stem cell transplantation.
Myelofibrosis Studies
The investigator explores therapeutic options for primary and secondary myelofibrosis, focusing on symptom management and disease control.
- Combined Treatment Approaches
- Spleen Volume Reduction Therapies
- Symptom Score Improvement Strategies
Their research includes investigations into novel therapeutic combinations for myelofibrosis management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.